Carl Friedrich Classen

1.4k total citations
37 papers, 617 citations indexed

About

Carl Friedrich Classen is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Carl Friedrich Classen has authored 37 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Carl Friedrich Classen's work include Glioma Diagnosis and Treatment (8 papers), Cancer Research and Treatments (6 papers) and Virus-based gene therapy research (4 papers). Carl Friedrich Classen is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Research and Treatments (6 papers) and Virus-based gene therapy research (4 papers). Carl Friedrich Classen collaborates with scholars based in Germany, United States and Latvia. Carl Friedrich Classen's co-authors include Klaus‐Michael Debatin, Claudia Maletzki, Björn Schneider, Michael Linnebacher, Tomas Fiedler, Bernd Kreikemeyer, Meinolf Suttorp, Doreen William, Wilhelm Friedrich and Ansgar Schulz and has published in prestigious journals such as Blood, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Carl Friedrich Classen

33 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Friedrich Classen Germany 17 206 121 120 114 104 37 617
Beryl Crossley United States 13 170 0.8× 41 0.3× 57 0.5× 240 2.1× 57 0.5× 22 796
Victoria Bedell United States 16 431 2.1× 108 0.9× 156 1.3× 181 1.6× 22 0.2× 40 1.0k
Iwona Auer Canada 13 114 0.6× 108 0.9× 118 1.0× 189 1.7× 19 0.2× 28 714
Melba L. Andres United States 14 181 0.9× 123 1.0× 40 0.3× 151 1.3× 68 0.7× 26 534
Jun Miyauchi Japan 18 357 1.7× 258 2.1× 75 0.6× 205 1.8× 29 0.3× 50 1.1k
Luigi Ombrato United Kingdom 10 388 1.9× 146 1.2× 25 0.2× 327 2.9× 29 0.3× 17 835
Josiane Martin France 17 192 0.9× 54 0.4× 237 2.0× 91 0.8× 13 0.1× 37 962
Massimiliano Mazza Italy 18 238 1.2× 48 0.4× 30 0.3× 309 2.7× 18 0.2× 42 725
Edmund J. Lovett United States 16 189 0.9× 166 1.4× 54 0.5× 154 1.4× 20 0.2× 35 696
Chie Kobayashi Japan 13 251 1.2× 117 1.0× 69 0.6× 59 0.5× 8 0.1× 45 665

Countries citing papers authored by Carl Friedrich Classen

Since Specialization
Citations

This map shows the geographic impact of Carl Friedrich Classen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Friedrich Classen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Friedrich Classen more than expected).

Fields of papers citing papers by Carl Friedrich Classen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Friedrich Classen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Friedrich Classen. The network helps show where Carl Friedrich Classen may publish in the future.

Co-authorship network of co-authors of Carl Friedrich Classen

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Friedrich Classen. A scholar is included among the top collaborators of Carl Friedrich Classen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Friedrich Classen. Carl Friedrich Classen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Classen, Carl Friedrich, et al.. (2025). Targeting PP2A in cancer: an underrated option. Journal of Experimental & Clinical Cancer Research. 44(1). 295–295.
2.
Cardesa‐Salzmann, Teresa M., Monika Sparber‐Sauer, Andreas Erbersdobler, et al.. (2024). On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion‐Positive Infantile Fibrosarcoma of the Head and Neck. Head & Neck. 47(5). E50–E57.
3.
Wild, Hannah, Michael Abele, Michael C. Frühwald, et al.. (2023). NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP). Pediatric Blood & Cancer. 71(3). e30821–e30821. 2 indexed citations
4.
Bozkurt, Süleyman, Michael C. Burger, Stefan Momma, et al.. (2023). Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells. Cancers. 15(21). 5249–5249.
5.
Abele, Michael, Christian Seitz, Abbas Agaimy, et al.. (2021). Primary lung carcinoma in children and adolescents – Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP). Lung Cancer. 160. 66–72. 8 indexed citations
6.
Schneider, Björn, Carl Friedrich Classen, Elisa Wirthgen, et al.. (2020). Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib. Frontiers in Immunology. 11. 55–55. 29 indexed citations
7.
Classen, Carl Friedrich, et al.. (2018). Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies. Cellular Physiology and Biochemistry. 51(2). 854–870. 64 indexed citations
8.
9.
Classen, Carl Friedrich, et al.. (2018). Adolescents and young adults with cancer: aspects of adherence – a questionnaire study. Adolescent Health Medicine and Therapeutics. Volume 9. 77–85. 10 indexed citations
10.
Maletzki, Claudia, Doreen William, Carl Friedrich Classen, et al.. (2017). Deciphering molecular mechanisms of arginine deiminase-based therapy – Comparative response analysis in paired human primary and recurrent glioblastomas. Chemico-Biological Interactions. 278. 179–188. 16 indexed citations
11.
Fiedler, Tomas, Sylvio Redanz, Doreen William, et al.. (2015). Arginine deprivation by arginine deiminase ofStreptococcus pyogenescontrols primary glioblastoma growthin vitroandin vivo. Cancer Biology & Therapy. 16(7). 1047–1055. 50 indexed citations
12.
Classen, Carl Friedrich. (2012). Pediatric palliative care - The role of the patient’s family. World Journal of Clinical Pediatrics. 1(3). 13–13. 4 indexed citations
13.
14.
Classen, Carl Friedrich, et al.. (2011). Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation. BMJ Case Reports. 2011. bcr0520114291–bcr0520114291. 2 indexed citations
15.
Classen, Carl Friedrich, Dieter Haffner, Horst Nizze, Peter Möller, & Friedrich Prall. (2010). Endolymphatic Non-Langerhans Cell Histiocytosis of the Larynx. Journal of Pediatric Hematology/Oncology. 32(5). e173–e176. 1 indexed citations
16.
Titze, Ulf, Gritta Janka, E. Marion Schneider, et al.. (2009). Hemophagocytic lymphohistiocytosis and Kawasaki disease: Combined manifestation and differential diagnosis. Pediatric Blood & Cancer. 53(3). 493–495. 35 indexed citations
17.
Wolff, Johannes, Carl Friedrich Classen, Sabine Wagner, et al.. (2008). Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. Journal of Neuro-Oncology. 87(2). 155–164. 31 indexed citations
18.
Schmidt, Katrin, Ansgar Schulz, Klaus‐Michael Debatin, Wilhelm Friedrich, & Carl Friedrich Classen. (2007). CNS complications in children receiving chemotherapy or hematopoietic stem cell transplantation: Retrospective analysis and clinical study of survivors. Pediatric Blood & Cancer. 50(2). 331–336. 18 indexed citations
19.
Classen, Carl Friedrich, et al.. (2006). LATE RESPONSE TO RADIOCHEMOTHERAPY IN PEDIATRIC GLIOBLASTOMA: Report on Two Patients Treated According to HIT-GBM Protocols. Pediatric Hematology and Oncology. 23(8). 631–637. 3 indexed citations
20.
Schulz, Ansgar, Carl Friedrich Classen, Markus Wiesneth, et al.. (2002). HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood. 99(9). 3458–3460. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beryl Crossley Breakdown of academic impact, for papers by Victoria Bedell Breakdown of academic impact, for papers by Iwona Auer Breakdown of academic impact, for papers by Melba L. Andres Breakdown of academic impact, for papers by Jun Miyauchi Breakdown of academic impact, for papers by Luigi Ombrato Breakdown of academic impact, for papers by Josiane Martin Breakdown of academic impact, for papers by Massimiliano Mazza Breakdown of academic impact, for papers by Edmund J. Lovett Breakdown of academic impact, for papers by Chie Kobayashi
Rankless by CCL
2026